Scribd
Upload
114 views25 pages

Health Sector

The document provides an overview of the global and Indian healthcare sectors. It notes that the Indian healthcare sector is valued at $34 billion, constituting 6% of India's GDP, and growing annually at 13%. Key segments include hospitals, pharmaceuticals, and medical tourism. The Indian healthcare industry has strengths such as low costs, an untapped market, and skilled workforce. However, it faces weaknesses like price discrimination and an incompetent public sector. Future growth drivers include rising incomes, urbanization, and increasing medical tourism.

Uploaded by

Kamalakkannan
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
114 views25 pages

Health Sector

The document provides an overview of the global and Indian healthcare sectors. It notes that the Indian healthcare sector is valued at $34 billion, constituting 6% of India's GDP, and growing annually at 13%. Key segments include hospitals, pharmaceuticals, and medical tourism. The Indian healthcare industry has strengths such as low costs, an untapped market, and skilled workforce. However, it faces weaknesses like price discrimination and an incompetent public sector. Future growth drivers include rising incomes, urbanization, and increasing medical tourism.

Uploaded by

Kamalakkannan
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 25

COUNTRY LIFE EXPECTANCY

CHINA 84.69
JAPAN 82.19
AUSTRALIA 81.32
INDIA 69.89

WANNA LIVE MORE?


BETTER WATCH THIS OUT!!
SECTOR IN INDIA
GLOBAL HEALTHCARE SECTOR:
AN OVERVIEW
World’s 2nd largest business sector
•

Global healthcare revenue US$ 2.8Trillion


•
INDIAN HEALTHCARE SECTOR

• VALUED AT US$ 34BILLION

• ANNUAL GROWTH OF 13%

• CONSTITUTES 6% OF THE GDP


HEALTHCARE SEGMENTS
• PUBLIC
State owned
Subsidized medicine
Free of cost treatment

• PRIVATE
80% market share
INDUSTRY SEGMENTS
• HOSPITALS

• PHARMACEUTICALS

• MEDICAL TOURISM
HOSPITALS

• MORE THAN 16000 HOSPITALS

• MORE THAN 9 LAKH BEDS

• GROWTH RATE OF 10-20%


MARKET PLAYERS
PHARMACEUTICALS
• ONE OF THE FASTEST GROWING
MARKETS IN THE WORLD

• ANNUAL GROWTH OF 17.5%

• CATERS TO 95% OF COUNTRY’S


NEEDS
MAJOR MARKET PLAYERS
MEDICAL TOURISM
• WORTH US$ 1.2BILLION AND IS ESTD., TO REACH US$
2.2BILLION BY 2012

• GROWTH RATE 12% PER ANNUM EXPECTED TO BE 30%


BY 2012

• MEDICAL TOURISTS ACCOUNTS TO 2.72 LAKH PER ANNUM


MAJOR MARKET PLAYERS
FORECAST
GROWTH DRIVERS
• RISING INCOME

• GROWING MIDDLE CLASS

• GROWING AND AGEING POPULATION

• GROWING URBANIZATION

• GROWING MEDICAL TOURISM

• HEALTHCARE INSURANCE PENETRATION


SWOT ANALYSIS
WEAKNESSES
STRENGTHS
• PRICE DESCRIMINATION

• COST EFFECTIVE • INCOMPETENT PUBLIC SECTOR

• LOW / CAPITA EXPENDITURE ($ 94)


• UNTAPPED MARKET

• COMPETITIVE WORK FORCE


SWOT ANALYSIS
OPPOTUNITIES THREATS

• POLICY MAKEOVER

• MEDICAL TOURISM

• USE OF IT
ADVANTAGE INDIA
• OVER 6,50,000 DOCTORS

• HIGHLY SKILLED EXPERTS

• EMERGING MAJOR R&D CENTRE

• LOW COST DRUG DEVELOPEMENT


ADVANTAGE INDIA - CONTD.,
• SECOND HIGHEST NUMBER OF QUALIFIED DOCTORS IN THE WORLD

• HIGHEST SUCCESS RATE IN CARDIAC SURGERY AND BONE MARROW TRANSPLANTATION

• THE COST ADVANTAGE

Procedure US ($) UK ($) India ($)


Angioplasty 30000 21000-27000 4000-5000
Angiography 2500-3000 2000 400
Hip replacement 19000 13000-16000 6000
Knee replacement 27000-32000 16000-18000 6000
CABG 30000 6400
Lasik 2250-2900 400
MEDICAL EDUCATION
• 230 MEDICAL COLLEGES

• 106 PRIVATE COLLEGES

• 29,000 DOCTORS QUALIFY ANNUALLY


80% OF THE MEDICAL FACILITIES ARE
CONCENTRATED IN THE URBAN AREA

WHILE 73% OF THE POPULATION RESIDES IN


THE RURAL AREA
HEALTHCARE DEMAND
DEMAND Vs SUPPLY
HEALTHCARE
INFRASTRUCTURE
THE ROAD AHEAD
• IMPROVEMENT IN PHYSICAL
INFRASTRUCTURE

• IMPLEMENTATION OF TELEMEDICINE

• COST EFFECTIVE CLINICAL TRIAL

• EFFECTIVE PUBLIC PRIVATE PARTNERSHIP


RAHUL
KAMAL
KARTHIGA
Department of
Management
Studies,
School of
Management,
Pondicherry university

You might also like